STOCK TITAN

West Wins Heart of Pharma Award at 2024 CPHI Pharma Awards

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

West Pharmaceutical Services, Inc. (NYSE: WST) has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center. The award recognizes philanthropic, ethical, and community-based ventures. West has been a philanthropic partner of Fox Chase for over 20 years and pledged support for a next-generation mobile screening unit in 2021.

The new state-of-the-art mobile screening unit, sponsored by West, will provide services later this year, offering:

  • Screening for more types of cancer
  • 3D mammography
  • Vaccine distribution
  • Phlebotomy
  • Collection of biospecimens and population data for cancer research

This initiative aims to increase access to cancer screenings in communities with healthcare access, demonstrating West's commitment to improving health and wellness in the communities they serve.

West Pharmaceutical Services, Inc. (NYSE: WST) ha ricevuto il Heart of Pharma Award ai premi CPHI 2024 per la sua collaborazione con il Fox Chase Cancer Center. Il premio riconosce iniziative filantropiche, etiche e basate sulla comunità. West è un partner filantropico del Fox Chase da oltre 20 anni e ha promesso supporto per un'unità di screening mobile di nuova generazione nel 2021.

La nuova unità di screening mobile all'avanguardia, sponsorizzata da West, offrirà servizi entro la fine dell'anno, con:

  • Screening per più tipi di cancro
  • Mammografia 3D
  • Distribuzione di vaccini
  • Flebotomia
  • Raccolta di biospecimens e dati sulla popolazione per la ricerca sul cancro

Questa iniziativa mira ad aumentare l'accesso agli screening per il cancro nelle comunità con accesso limitato alla sanità, dimostrando così l'impegno di West a migliorare la salute e il benessere delle comunità che servono.

West Pharmaceutical Services, Inc. (NYSE: WST) ha sido galardonada con el Heart of Pharma Award en los premios CPHI 2024 por su colaboración con el Fox Chase Cancer Center. El premio reconoce las iniciativas filantrópicas, éticas y comunitarias. West ha sido un socio filantrópico de Fox Chase durante más de 20 años y se comprometió a apoyar una unidad de detección móvil de nueva generación en 2021.

La nueva unidad de detección móvil de última generación, patrocinada por West, proporcionará servicios a finales de este año, ofreciendo:

  • Detección para más tipos de cáncer
  • Mamografía 3D
  • Distribución de vacunas
  • Flebotomía
  • Recolección de biospecímenes y datos de población para la investigación sobre el cáncer

Esta iniciativa tiene como objetivo aumentar el acceso a las detecciones de cáncer en comunidades con acceso limitado a la atención médica, demostrando el compromiso de West de mejorar la salud y el bienestar de las comunidades a las que sirven.

West Pharmaceutical Services, Inc. (NYSE: WST)는 Fox Chase Cancer Center와의 파트너십으로 2024 CPHI Awards에서 Heart of Pharma Award를 수상했습니다. 이 상은 자선, 윤리 및 지역 사회 기반의 사업을 인정하는 것입니다. West는 Fox Chase의 자선 파트너로 20년 이상 활동했으며, 2021년에 차세대 이동식 검진 단위를 지원할 것을 약속했습니다.

West가 후원하는 최첨단 이동식 검진 단위는 올해 말에 서비스를 제공하며, 다음과 같은 서비스를 제공합니다:

  • 더 많은 종류의 암 검진
  • 3D 유방촬영술
  • 백신 배포
  • 채혈
  • 암 연구를 위한 생물 샘플 및 인구 데이터 수집

이 계획은 의료 접근성이 제한된 지역 사회에서 암 검진의 접근성을 높이는 것을 목표로 하며, West가 그들이 제공하는 지역 사회의 건강과 웰빙을 개선하려는 노력을 보여줍니다.

West Pharmaceutical Services, Inc. (NYSE: WST) a reçu le Heart of Pharma Award lors des CPHI Awards 2024 pour son partenariat avec le Fox Chase Cancer Center. Ce prix reconnaît les initiatives philanthropiques, éthiques et communautaires. West est un partenaire philanthropique du Fox Chase depuis plus de 20 ans et a promis de soutenir une unité de dépistage mobile de nouvelle génération en 2021.

La nouvelle unité de dépistage mobile à la pointe de la technologie, sponsorisée par West, fournira des services plus tard cette année, offrant :

  • Dépistage pour d'autres types de cancer
  • Mammographie 3D
  • Distribution de vaccins
  • Phlébotomie
  • Collecte de biospécimens et de données sur la population pour la recherche sur le cancer

Cette initiative vise à augmenter l'accès aux dépistages du cancer dans les communautés ayant un accès limité aux soins de santé, démontrant ainsi l'engagement de West à améliorer la santé et le bien-être des communautés qu'ils servent.

West Pharmaceutical Services, Inc. (NYSE: WST) wurde mit dem Heart of Pharma Award bei den CPHI Awards 2024 für ihre Partnerschaft mit dem Fox Chase Cancer Center ausgezeichnet. Der Preis würdigt philanthropische, ethische und gemeinschaftsorientierte Vorhaben. West ist seit über 20 Jahren ein philanthropischer Partner von Fox Chase und hat 2021 Unterstützung für eine mobile Screening-Einheit der nächsten Generation zugesagt.

Die neue hochmoderne mobile Screening-Einheit, die von West gesponsert wird, wird später in diesem Jahr Dienstleistungen anbieten, darunter:

  • Screening für weitere Krebsarten
  • 3D-Mammographie
  • Verteilung von Impfstoffen
  • Phlebotomie
  • Sammlung von Biospezimen und Bevölkerungsdaten für die Krebsforschung

Diese Initiative zielt darauf ab, den Zugang zu Krebsscreenings in Gemeinschaften mit eingeschränktem Gesundheitszugang zu erhöhen, und zeigt Wests Engagement für die Verbesserung der Gesundheit und des Wohlbefindens der Gemeinschaften, in denen sie tätig sind.

Positive
  • None.
Negative
  • None.

EXTON, Pa., Oct. 9, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce that it has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center, a part of the Temple University Health System. This award recognizes companies, individuals, and initiatives which nurture philanthropic, ethical and community-based ventures. West was announced the winner during an awards ceremony on the opening night of CPHI Worldwide on October 8 in Milan, Italy.

West has been a philanthropic partner of Fox Chase Cancer Center, a Philadelphia-based comprehensive cancer center committed to clinical excellence, research expertise, and community health, for over two decades. In 2021, West pledged to support a next-generation mobile screening unit, building on Fox Chase's three decades of experience as a leader in mobile cancer screening. With the help of funds raised by West team members, Fox Chase announced a new state-of-the-art mobile screening unit sponsored by West that will provide services later this year. This mobile screening van will increase Fox Chase's capacity to bring cancer screenings directly into communities with limited access to healthcare.  The new unit will offer screening for more types of cancer, 3D mammography, and new initiatives, like vaccine distribution, phlebotomy, and collection of biospecimens and population data to advance cancer research.

"We are honored to receive this recognition from CPHI and grateful to serve as a partner with Fox Chase Cancer Center, helping to make a difference in the fight against cancer," said Eric Green, West President and CEO. "West is proud to be by the side of research centers like Fox Chase and remain committed together to improving the overall health and wellness of the communities we serve."

"On behalf of the faculty, staff and patients at Fox Chase Cancer Center, I would like to offer my sincere and heartfelt congratulations on this award," said Robert Uzzo, MD, MBA, FACP, Fox Chase Cancer Center President & CEO. "As we work to fulfill our mission for our community, philanthropy plays a huge role, and West has always been one of our most generous partners. We are grateful for their support."

For more information about CPHI Worldwide, please visit:  At the heart of Pharma | CPHI Milan

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.   

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/west-wins-heart-of-pharma-award-at-2024-cphi-pharma-awards-302270777.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

What award did West Pharmaceutical Services (WST) win at the 2024 CPHI Pharma Awards?

West Pharmaceutical Services (WST) won the Heart of Pharma Award at the 2024 CPHI Pharma Awards for its partnership with Fox Chase Cancer Center.

How is West Pharmaceutical Services (WST) supporting Fox Chase Cancer Center?

West Pharmaceutical Services (WST) is supporting Fox Chase Cancer Center by sponsoring a new state-of-the-art mobile screening unit that will provide cancer screening services to communities with healthcare access.

What services will the new mobile screening unit sponsored by West Pharmaceutical Services (WST) offer?

The new mobile screening unit will offer screening for more types of cancer, 3D mammography, vaccine distribution, phlebotomy, and collection of biospecimens and population data for cancer research.

When will the new mobile screening unit sponsored by West Pharmaceutical Services (WST) begin providing services?

The new mobile screening unit sponsored by West Pharmaceutical Services (WST) is expected to begin providing services later in 2024.

How long has West Pharmaceutical Services (WST) been a philanthropic partner of Fox Chase Cancer Center?

West Pharmaceutical Services (WST) has been a philanthropic partner of Fox Chase Cancer Center for over two decades.

West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

WST Latest News

WST Stock Data

22.03B
72.00M
0.58%
96.52%
1.98%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
EXTON